ZFP161 / ZBTB14 Polyclonal antibody

ZFP161 / ZBTB14 Polyclonal Antibody for WB, ELISA
Cat No. 22056-1-AP

产品说明书

宿主/亚型

Rabbit / IgG

种属反应性

human

应用

WB, ELISA

hZF5, ZBTB14, ZF5, Zfp 161, Zfp 5, ZFP161, Zinc finger protein 5 homolog, ZNF478

缓冲液配方:  PBS and Azide
PBS and Azide
偶联物:  Unconjugated
Unconjugated
规格: 

-/ -


经过测试的应用

Positive WB detected inHEK-293 cells, L02 cells
Planning an IHC experiment? We recommend our IHCeasy ZFP161 Ready-To-Use IHC Kit. ZFP161 primary antibody included.

推荐稀释比

应用推荐稀释比
Western Blot (WB)WB : 1:1000-1:6000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

22056-1-AP targets ZFP161 / ZBTB14 in WB, ELISA applications and shows reactivity with human samples.

经测试应用 WB, ELISA Application Description
经测试反应性 human
免疫原 ZFP161 / ZBTB14 fusion protein Ag17082 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Polyclonal
产品类型 Antibody
全称 zinc finger protein 161 homolog (mouse)
别名 hZF5, ZBTB14, ZF5, Zfp 161, Zfp 5, ZFP161, Zinc finger protein 5 homolog, ZNF478
计算分子量 449 aa, 51 kDa
观测分子量55 kDa
GenBank蛋白编号BC110519
基因名称 ZFP161
Gene ID (NCBI) 7541
RRIDAB_3085683
偶联类型 Unconjugated
形式 Liquid
纯化方式Antigen affinity purification
UNIPROT IDO43829
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

ZBTB14, also named as :ZFP161, ZNF478, is a 449 amino acid protein, which interacts with ZBTB21. ZBTB14, is a transcriptional activator of the dopamine transporter (DAT), binding it's promoter at the consensus sequence 5'-CCTGCACAGTTCACGGA-3'. ZBTB14 Binds to 5'-d(GCC)(n)-3' trinucleotide repeats in promoter regions and acts as a repressor of the FMR1 gene. The calculated MW of ZFP161 is 52 kDa, 22056-1-AP can detect a band around 55 kDa.

实验方案

Product Specific Protocols
WB protocol for ZFP161 / ZBTB14 antibody 22056-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...